Skip to main content
Log in

Genetic testing in sudden unexpected natural death in the young: New York City Office of Chief Medical Examiner’s experience and perspective

  • Commentary
  • Published:
Forensic Science, Medicine and Pathology Aims and scope Submit manuscript

Abstract

Postmortem genetic testing is a diagnostic tool that is becoming increasingly utilized. The benefits and limitations of genetic testing in cases of sudden, unexpected death in the young (≤ 40 years old) are reviewed from the perspective of the Office of Chief Medical Examiner of the City of New York, whose Molecular Genetics Laboratory, accredited by College of American Pathologists, has had 15 years of postmortem testing experience. Challenges to the interpretation and communication of testing results are highlighted, and opportunities for improving testing yield are discussed for age groups across the lifespan, from infancy to adulthood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wang D, Shah KR, Um SY, et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. Forensic Sci Int. 2014;237:90–9.

    Article  CAS  PubMed  Google Scholar 

  2. Lin Y, Williams N, Wang D, et al. Applying high-resolution variant classification to cardiac arrhythmogenic gene testing in a demographically diverse cohort of sudden unexplained deaths. Circ Cardiovasc Genet. 2017;10(6). https://doi.org/10.1161/CIRCGENETICS.117.001839

  3. Duncan JR, Paterson DS, Hoffman JM, et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA. 2010;303:430–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Haynes RL, Frelinger AL 3rd, Giles EK, et al. High serum serotonin in sudden infant death syndrome. Proc Natl Acad Sci U S A. 2017;114:7695–700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sadeh D, Shannon DC, Abboud S, Saul JP, Akselrod S, Cohen RJ. Altered cardiac repolarization in some victims of sudden infant death syndrome. N Engl J Med. 1987;317:1501–5.

    Article  CAS  PubMed  Google Scholar 

  6. Perticone F, Ceravolo R, Maio R, Cosco C, Mattioli PL. Heart rate variability and sudden infant death syndrome. Pacing Clin Electrophysiol. 1990;13:2096–9.

    Article  CAS  PubMed  Google Scholar 

  7. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med. 1998;338:1709–14.

    Article  CAS  PubMed  Google Scholar 

  8. Neyroud N, Tesson F, Denjoy I, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet. 1997;15:186–9.

    Article  CAS  PubMed  Google Scholar 

  9. Gando I, Morganstein J, Jana K, McDonald TV, Tang Y, Coetzee WA. Infant sudden death: Mutations responsible for impaired Nav1.5 channel trafficking and function. Pacing Clin Electrophysiol. 2017;40:703–12.

    Article  PubMed  Google Scholar 

  10. Tester DJ, Wong LCH, Chanana P, et al. Exome-wide rare variant analyses in sudden infant death syndrome. J Pediatr. 2018;203:423–8 e11.

    Article  PubMed  Google Scholar 

  11. Mates J, Mademont-Soler I, Del Olmo B, et al. Role of copy number variants in sudden cardiac death and related diseases: genetic analysis and translation into clinical practice. Eur J Hum Genet. 2018;26:1014–25.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Yoshinaga M, Kucho Y, Ushinohama H, Ishikawa Y, Ohno S, Ogata H. Autonomic function and QT interval during night-time sleep in infant long QT syndrome. Circ J. 2018;82:2152–9.

    Article  PubMed  Google Scholar 

  13. Weintraub RG, Gow RM, Wilkinson JL. The congenital long QT syndromes in childhood. J Am Coll Cardiol. 1990;16:674–80.

    Article  CAS  PubMed  Google Scholar 

  14. Georgievskaya Z, Tang Y, Williams N, Sampson B, Gelb BD, Kontorovich AR. Fatal myocarditis is associated with rare cardiomyopathy gene variants. Circulation. 2018;136:A18206.

    Google Scholar 

  15. Tang Y, Sampson B, Pack S, et al. Ethnic differences in out-of-hospital fatal pulmonary embolism. Circulation. 2011;123:2219–25.

    Article  PubMed  Google Scholar 

  16. Halvorsen M, Lin Y, Sampson BA, et al. Whole exome sequencing reveals severe thrombophilia in acute unprovoked idiopathic fatal pulmonary embolism. EBioMedicine. 2017;17:95–100.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Gago-Diaz M, Ramos-Luis E, Zoppis S, et al. Postmortem genetic testing should be recommended in sudden cardiac death cases due to thoracic aortic dissection. Int J Legal Med. 2017;131:1211–9.

    Article  PubMed  Google Scholar 

  18. Chen J, Weber M, Um SY, Walsh CA, Tang Y, McDonald TV. A dual mechanism for I (Ks) current reduction by the pathogenic mutation KCNQ1-S277L. Pacing Clin Electrophysiol. 2011;34:1652–64.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2004;36:1162–4.

    Article  CAS  PubMed  Google Scholar 

  20. Williams N, Marion R, McDonald TV, et al. Phenotypic variations in carriers of predicted protein-truncating genetic variants in MYBPC3: an autopsy-based case series. Cardiovasc Pathol. 2018;37:30–3.

    Article  CAS  PubMed  Google Scholar 

  21. Sampson BA, Tang Y. Holistic approach to determine cause of autopsy-negative sudden natural death. J Am Coll Cardiol. 2017;69:2146–8.

    Article  PubMed  Google Scholar 

Download references

Funding

Grant awards (2015-DN-BX-K017 and 2014-DN-BX-K001) by National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yingying Tang.

Ethics declarations

Review article (no identifiable information is used).

Conflict of interest

None.

Ethical approval

Office of Chief Medical Examiner of the City of New York approved this work.

Informed consent

Review article (no identifiable information is used).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, Y., Williams, N. & Sampson, B.A. Genetic testing in sudden unexpected natural death in the young: New York City Office of Chief Medical Examiner’s experience and perspective. Forensic Sci Med Pathol 15, 481–484 (2019). https://doi.org/10.1007/s12024-018-0068-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12024-018-0068-6

Keywords

Navigation